Скачать или смотреть IBRX Stock Analysis | IBRX is EXPLODING as Predicted! - Next Price Target?

The setup we flagged weeks ago just delivered a 41.9% single session move and the next catalyst is days away. Now the next leg could be even bigger, and you need to see this before the week begins.

✅ What We Cover In This Video:
• How our Feb 10 advisory predicted the exact $5.94 dip and $6.02 entry
• Why the EU authorization of Anktiva triggered a 41.9% single-session explosion
• BlackRock, Vanguard & Goldman Sachs quietly loading massive positions
• Why IBRX is now 52%+ institutionally controlled for the first time ever
• The Saudi Arabia pivot most analysts are completely sleeping on
• Golden Cross signal and what it means for the long-term trend
• The short squeeze powder keg — 135 million shares on the wrong side
• Tactical buy zone, price targets & stop loss for Feb 24 – March 1
• Two massive catalysts arriving this week: ASCO Symposium & March 2 Earnings

📊 Key Numbers To Know:
• $113 Million — Fiscal 2025 preliminary net revenue
• 700% — Year-over-year revenue growth
• 33 — Countries with regulatory authorization
• 52.35% — Float now controlled by 355 institutions
• 13.7% — Record short interest (135M shares short)
• $20.69 — DCF intrinsic fair value per share
• $24.00 — Boral Capital analyst price target
• $8.30–$8.55 — Current tactical buy zone
• $9.50–$10.25 — Near-term price targets

⚡ 5 Critical Factors Driving This Setup:
• Institutional Tsunami — BlackRock (+29%), Vanguard (+18.5%) & Goldman all buying simultaneously
• Revenue Explosion — 700% YoY growth signals full commercial-stage transformation
• Global Regulatory Moat — FDA, MHRA, EMA & SFDA authorization across 33 countries
• Short Squeeze Ignition Risk — 1.7 days-to-cover with two catalysts hitting this week
• Valuation Gap — Stock still trading at nearly 50% discount to DCF fair value even after the rally

This is one of the most well-supported setups we have broken down on Stocks With David in months — fundamentals, technicals, and institutional conviction all pointing in the same direction at the same time. Drop your price target in the comments and let the community know where you think IBRX goes next.

👇 SUBSCRIBE TO STOCKS WITH DAVID NOW 👇

📈 ABOUT STOCKS WITH DAVID
Welcome to Stocks with David! My channel is dedicated to helping you navigate the US Stock Market and the NASDAQ.
Whether you are looking for daily market updates, deep dives into tech stocks or long-term investing strategies, this channel provides the data and analysis you need. I break down complex financial charts and news into simple, actionable insights to help you build wealth and manage your portfolio.
⚠️ DISCLAIMER: NOT FINANCIAL ADVICE
The content provided on the Stocks with David YouTube channel and in this video is for entertainment and educational purposes only. I am not a professional financial advisor.
#stockmarket #ibrxstock #ShortSqueeze #Stocks With David #ibrx